Danaher - DHR Net Assets per Single Share

Graphic logo of Danaher (DHR)

The stability of long-term contracts mitigates the risks of declining demand for biotech consumables for Danaher Corp. (DHR). The book value per share confirms this trend, with the current level standing at 75.74. Growth is driven by the benchmark DBS system and mastery of resource allocation. Efficiency is further based on outsourcing IT support and portions of production to external partners to maximize profits.

DHR: Danaher Corporation Net Asset Value per Share 07/04/2022 - 10/28/2026

Summary analytical data breakdowns for danaher.com (DHR)

- price and consensus price forecast:
Price Chart Danaher Corp|DHR - Fair Value Consensus
- market capitalization data:
Market Value Danaher Corporation|DHR - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Danaher|DHR - Total Stockholders' Equity|Market Capitalization to Book Value Ratio danaher.com|DHR - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Danaher Corp.|DHR - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Danaher|DHR - Company Total Debt|Debts to Book Capitalization Danaher Corporation|DHR - Company Long-Term Debts|Company Short-Term Debt Danaher
Analysis of all company metrics:Danaher Corp (DHR)
Product sample of danaher.com

Investors often seek capital protection from market volatility by assessing tangible assets, and the aggressive acquisition of innovative biomedical startups by Danaher Corp. (DHR) strengthens this foundation. This metric reflects the remaining equity per share after deducting all liabilities. By analyzing the book value per share trend, one can assess the real growth of net assets. A steady increase in this metric confirms the internal resilience of the business.

Competitor analysis for Danaher Corp.

Net Assets per Single Share Intuitive Surgical Inc (ISRG)|BDX: Accounting Value of a Share|STE (STERIS plc) - Net Assets per Single Share|westpharma.com (WST) - Accounting Value per Share|Book Value per Share BAX (Baxter)|Net Asset Value per Share Masimo Corp|Book Value per Share Stevanato STVN|Equity per Share Teleflex Corp (TFX)|Book Value per Share MMSI|Net Assets per Share envistaco.com NVST|ICUI: Book Value per Share|XRAY - Accounting Value per Share|LMAT: Book Value per Share|ATRC (AtriCure Medical) - Book Value per Share|Net Assets per Single Share STAAR Surgical Company|Net Assets per Single Share Niagen (NAGE)|ZimVie (ZIMV) - Accounting Value per Share|Accounting Value of a Share AngioDynamics Inc (ANGO)|Book Value per Share CERS|Teknova Inc - Net Assets per Share|Monogram Technologies (MGRM) - Net Assets per Single Share|STSS: Equity per Share|infusystem.com - Net Assets per Single Share|Net Assets per Share Utah Medical Products Inc.|KORU Medical Systems, Inc. (KRMD) - Accounting Value per Share|Book Price of a Share NYXH|Microbot Medical Inc. (MBOT) - Net Assets per Single Share|Accounting Value of a Share pro-dex.com PDEX|Accounting Value per Share ZTEK (Zentek)|Elutia Inc - Book Value per Share|MLSS: Net Assets per Single Share|NXGL - Accounting Value per Share|Book Value per Share RVP|HBIO (harvardbioscience.com) - Net Asset Value per Share|Net Assets per Single Share Femasys (FEMY)|Equity per Share Meihua Medical (MHUA)|Accounting Value per Share Predictive Oncology|Book Price of a Share CJMB (callanjmb.com)|Net Assets per Single Share ATRI|Net Assets per Share neurometrix.com NURO